[Ip-health] Oct 2 Panel at AU Law School: US Trade Policy and Access to HIV/AIDS
Medicines in Africa and the Caribbean
Mike Palmedo
mpalmedo@wcl.american.edu
Wed Sep 26 06:12:04 2007
http://www.wcl.american.edu/pijip/documents/access10022007.pdf?rd=1
US Trade Policy and Access to HIV/AIDS Medicines in Africa and the Caribbean
American University, Washington College of Law
4910 Massachusetts Ave., NW Washington, DC
October 2, 2007 | Room 603 | 6pm
At least 24 million people with HIV/AIDS are living in Africa and the
Caribbean, many of which need access to antiretroviral treatment
immediately. Yet these drugs remain out of reach for the vast majority
of them. This PIJIP/Black Law Student Association-sponsored panel will
examine the possible links between US trade policy, the pharmaceutical
industry, and the availability of HIV/AIDS medicines in Africa and the
Caribbean. It will discuss the intellectual property rules set up by the
World Trade Organization and in subsequent bilateral Free Trade
Agreements, and how these rules may hinder generic competition.
Additionally, the panel will look to current and future topics of
concern, such as the significantly higher prices charged for
second-generation treatments, and discussions at the World Health
Organization over how to simultaneously provide affordable treatment and
provide funding for further health research.
Moderator:
Professor Daniel Bradlow
Director of the International Legal Studies Program
Panelists:
Matthew Kavanaugh
Director, Student Global AIDS Campaign
Sean Flynn
Associate Director, PIJIP
Judit Rius
Attorney, Knowledge Ecology Project
Chris Wilson
Acting Assistant US Trade Representative for Intellectual Property and
Innovation
--
Mike Palmedo
Research Coordinator
Program on Information Justice and Intellectual Property
American University, Washington College of Law
4910 Massachutsetts Ave., NW Washington, DC 20016
T - 202-274-4442 | F 202-274-0659
mpalmedo@wcl.american.edu